Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Pharma AGfiledCriticalBayer Pharma AG
Priority claimed from PCT/EP2014/064547external-prioritypatent/WO2015004105A1/en
Publication of MA38775A1publicationCriticalpatent/MA38775A1/en
L'invention concerne une nouvelle benzyl-1h-pyrazolo[3,4-b]pyridine, son procédé de préparation, son utilisation seule ou dans des combinaisons pour le traitement et/ou la prophylaxie de maladies, ainsi que son utilisation pour la préparation de médicaments servant au traitement et/ou à la prophylaxie de maladies, en particulier au traitement et/ou à la prophylaxie de maladies du circuit cardiaque.The invention relates to a novel benzyl-1h-pyrazolo [3,4-b] pyridine, process for its preparation, use alone or in combinations for the treatment and / or prophylaxis of diseases, as well as its use for the preparation medicaments for the treatment and / or prophylaxis of diseases, in particular the treatment and / or prophylaxis of diseases of the cardiac circuit.
MA38775A2013-07-102014-07-08
Benzyl-1h-pyrazolo [3,4-b] pyridine and use thereof
MA38775A1
(en)
N- [4- (quinolin-4-yloxy) cyclohexyl (methyl)] (hetero) arylcarboxamides for use as androgen receptor antagonists, their production and their use as medicaments